報價延遲最少15分鐘:2025/05/30 14:14 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
48.69 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
6.51/-1.58
|
|
企業價值
6.07B
|
| 資產負債 |
|
每股賬面淨值
-2.34
|
| 現金流量 |
|
現金流量率
0.18
|
| 損益表 |
|
收益
806.78M
|
|
每股收益
10.07
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/05/30 14:14 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science. |